Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Preparation and Reactions of Thiols02:33

Preparation and Reactions of Thiols

Thiols are prepared using the hydrosulfide anion as a nucleophile in a nucleophilic substitution reaction with alkyl halides. For instance, bromobutane reacts with sodium hydrosulfide to give butanethiol.
Antidotes01:17

Antidotes

Antidotes are medicinal substances used to counteract the harmful effects of toxins or drugs in the body. They function in various ways, each uniquely designed to combat specific toxic compounds.
Specific antidotes operate by inhibiting the enzymes that control biochemical pathways, reducing the production of harmful metabolites.
An example of an antidote is atropine, which counteracts the detrimental effects of cholinesterase inhibitors. It achieves this by deactivating muscarinic receptors,...
Toxic Reactions: Overview01:26

Toxic Reactions: Overview

When toxic substances penetrate the human body, they disseminate to various tissues, undergoing metabolic changes. This process yields reactive metabolites that may covalently bind with specific target molecules, resulting in toxicity.
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
Drug Toxicity: Dose-Dependent Reactions01:24

Drug Toxicity: Dose-Dependent Reactions

Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...
Phase II Reactions: Glutathione Conjugation and Mercapturic Acid Formation01:22

Phase II Reactions: Glutathione Conjugation and Mercapturic Acid Formation

Glutathione, a tripeptide made up of glutamate, cysteine, and glycine, is a critical player in the detoxification of drugs and xenobiotics via a process known as glutathione conjugation or mercapturic acid formation. This phase II biotransformation reaction involves the covalent binding of glutathione to a drug or its metabolite, enhancing the compound's water solubility and enabling its excretion.
Several distinctive characteristics distinguish glutathione conjugation from other phase II...
Antiprotozoal Agents01:21

Antiprotozoal Agents

Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cadmium-Induced Neuroendocrine Alterations: Gene Expression of the Kisspeptin-GnRH Axis and Delayed Puberty in Male Rats.

Toxics·2026
Same author

Antidepressant-like effect of hydroxytyrosol in a 1-methyl-4-phenylpyridinium model of Parkinson's disease in rats.

Neurochemical research·2026
Same author

Enhanced Leaching of Soluble Lead by Cooking Acidic Food in Glazed Pottery Sold at the Mexico-US Border.

Journal of public health management and practice : JPHMP·2026
Same author

Corrigendum to: Armodafinil as a Potential Pharmacological Treatment for Attention Deficit Hyperactivity Disorder in Adults: A Review.

Current neuropharmacology·2026
Same author

The Effect of <i>Mucuna pruriens</i> on Depression-like Behavior Induced by a Mild Traumatic Brain Injury in Rats Is Associated with a Decrease in Brain Nitrite and Nitrate Levels.

NeuroSci·2025
Same author

Plasma Glutathione Concentrations Are Associated with Leukocyte and Neutrophils' Counts in Clozapine-Treated Patients.

Pharmaceuticals (Basel, Switzerland)·2025

Related Experiment Video

Updated: Jul 14, 2026

High-throughput Screening for Small-molecule Modulators of Inward Rectifier Potassium Channels
10:07

High-throughput Screening for Small-molecule Modulators of Inward Rectifier Potassium Channels

Published on: January 27, 2013

Endogenous thiols enhance thallium toxicity.

Sergio Montes1, Luz Soriano, Camilo Ríos

  • 1Departamento de Neuroquímica, Instituto Nacional de Neurología y Neurocirugía, Manuel Velasco Suárez, Av. Insurgentes Sur No. 3877, C.P. 14269, México, D.F, México.

Archives of Toxicology
|June 15, 2007
PubMed
Summary

L-methionine and L-cysteine treatments are ineffective against thallium toxicity in rats, even when combined with Prussian blue. These amino acids failed to reduce thallium levels or prevent mortality, indicating they are unsuitable antidotes.

More Related Videos

Synthesis and Bioconjugation of Thiol-Reactive Reagents for the Creation of Site-Selectively Modified Immunoconjugates
08:47

Synthesis and Bioconjugation of Thiol-Reactive Reagents for the Creation of Site-Selectively Modified Immunoconjugates

Published on: March 6, 2019

Resin-Assisted Capture Coupled with Isobaric Tandem Mass Tag Labeling for Multiplexed Quantification of Protein Thiol Oxidation
07:16

Resin-Assisted Capture Coupled with Isobaric Tandem Mass Tag Labeling for Multiplexed Quantification of Protein Thiol Oxidation

Published on: June 21, 2021

Related Experiment Videos

Last Updated: Jul 14, 2026

High-throughput Screening for Small-molecule Modulators of Inward Rectifier Potassium Channels
10:07

High-throughput Screening for Small-molecule Modulators of Inward Rectifier Potassium Channels

Published on: January 27, 2013

Synthesis and Bioconjugation of Thiol-Reactive Reagents for the Creation of Site-Selectively Modified Immunoconjugates
08:47

Synthesis and Bioconjugation of Thiol-Reactive Reagents for the Creation of Site-Selectively Modified Immunoconjugates

Published on: March 6, 2019

Resin-Assisted Capture Coupled with Isobaric Tandem Mass Tag Labeling for Multiplexed Quantification of Protein Thiol Oxidation
07:16

Resin-Assisted Capture Coupled with Isobaric Tandem Mass Tag Labeling for Multiplexed Quantification of Protein Thiol Oxidation

Published on: June 21, 2021

Area of Science:

  • Toxicology
  • Pharmacology
  • Biochemistry

Background:

  • Acute thallium (Tl) toxicity poses a significant health risk.
  • Effective antidotal treatments for thallium poisoning are crucial.
  • Amino acids like L-methionine (L-met) and L-cysteine (L-cys) have been explored for potential therapeutic roles.

Purpose of the Study:

  • To evaluate the efficacy of L-methionine and L-cysteine, alone and in combination with Prussian blue (PB), as treatments for acute thallium toxicity in rats.
  • To assess the impact of these treatments on thallium accumulation in tissues and overall survival rates.

Main Methods:

  • Rats were intoxicated with thallium acetate (32 mg/kg or 16 mg/kg).
  • Antidotal treatments included vehicle, L-met, L-cys, PB, L-met + PB, and L-cys + PB, administered over four days.
  • Mortality rates and thallium tissue levels in organs and brain regions were analyzed.

Main Results:

  • L-methionine and L-cysteine alone did not improve survival or reduce thallium levels.
  • Prussian blue alone significantly reduced thallium content in organs and brain.
  • Combinations of L-met/L-cys with PB did not enhance the protective effect of PB and showed high mortality rates (90-100%).

Conclusions:

  • L-methionine and L-cysteine are not suitable antidotes for acute thallium toxicity, individually or combined with Prussian blue.
  • These amino acid treatments failed to prevent mortality and reduce thallium accumulation, particularly in the brain.
  • Prussian blue remains a key agent for reducing thallium burden, but co-administration with L-met/L-cys is detrimental.